期刊
INFLAMMATORY BOWEL DISEASES
卷 21, 期 7, 页码 1674-1682出版社
OXFORD UNIV PRESS INC
DOI: 10.1097/MIB.0000000000000364
关键词
Crohn's disease; intestinal microbiota; probiotics; prebiotics; ulcerative colitis
资金
- Iuventus Plus program of the Polish Ministry of Science and Higher Education [0107/IP1/2013/72]
- Medical University of Lodz [503/1-156-04/503-01]
- National Science Centre [UMO-2013/11/B/NZ7/01301]
- Deutsche Forschungsgemeinschaft [DFG STO9-1]
Inflammatory bowel disease (IBD) is a group of diseases characterized by inflammation of the small and large intestine and primarily includes ulcerative colitis and Crohn's disease. Although the etiology of IBD is not fully understood, it is believed to result from the interaction of genetic, immunological, and environmental factors, including gut microbiota. Recent studies have shown a correlation between changes in the composition of the intestinal microbiota and IBD. Moreover, it has been suggested that probiotics and prebiotics influence the balance of beneficial and detrimental bacterial species, and thereby determine homeostasis versus inflammatory conditions. In this review, we focus on recent advances in the understanding of the role of prebiotics, probiotics, and synbiotics in functions of the gastrointestinal tract and the induction and maintenance of IBD remission. We also discuss the role of psychobiotics, which constitute a novel class of psychotropic agents that affect the central nervous system by influencing gut microbiota.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据